Advertisement
UK markets close in 2 hours 32 minutes
  • FTSE 100

    7,964.07
    +32.09 (+0.40%)
     
  • FTSE 250

    19,876.39
    +65.73 (+0.33%)
     
  • AIM

    744.00
    +1.89 (+0.25%)
     
  • GBP/EUR

    1.1695
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2648
    +0.0010 (+0.08%)
     
  • Bitcoin GBP

    56,067.68
    +736.64 (+1.33%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,250.48
    +1.99 (+0.04%)
     
  • DOW

    39,760.47
    +0.39 (+0.00%)
     
  • CRUDE OIL

    82.33
    +0.98 (+1.20%)
     
  • GOLD FUTURES

    2,230.00
    +17.30 (+0.78%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,494.21
    +17.12 (+0.09%)
     
  • CAC 40

    8,219.07
    +14.26 (+0.17%)
     

Moderna, Inc. (MRNA) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor inModerna, Inc. MRNA. The stock has moved higher by 29% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider MRNA’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as MRNA has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

ADVERTISEMENT

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research